Search by Drug Name or NDC

    NDC 00113-1720-02 Nasonex 50 ug/1 Details

    Nasonex 50 ug/1

    Nasonex is a NASAL SPRAY in the HUMAN OTC DRUG category. It is labeled and distributed by L. Perrigo Company. The primary component is MOMETASONE FUROATE MONOHYDRATE.

    Product Information

    NDC 00113-1720
    Product ID 0113-1720_695ed773-4a7f-462e-9352-13c000e06e4e
    Associated GPIs
    GCN Sequence Number 083194
    GCN Sequence Number Description mometasone furoate SPRAY/PUMP 50 MCG NASAL
    HIC3 Q7P
    HIC3 Description NASAL ANTI-INFLAMMATORY STEROIDS
    GCN 52083
    HICL Sequence Number 003329
    HICL Sequence Number Description MOMETASONE FUROATE
    Brand/Generic Brand
    Proprietary Name Nasonex
    Proprietary Name Suffix n/a
    Non-Proprietary Name mometasone furoate
    Product Type HUMAN OTC DRUG
    Dosage Form SPRAY
    Route NASAL
    Active Ingredient Strength 50
    Active Ingredient Units ug/1
    Substance Name MOMETASONE FUROATE MONOHYDRATE
    Labeler Name L. Perrigo Company
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215712
    Listing Certified Through 2024-12-31

    Package

    NDC 00113-1720-02 (00113172002)

    NDC Package Code 0113-1720-02
    Billing NDC 00113172002
    Package 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-02) / 120 SPRAY in 1 BOTTLE, SPRAY
    Marketing Start Date 2022-06-29
    NDC Exclude Flag N
    Pricing Information N/A